Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö > Ç×ü/¸é¿ª > U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1590)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (51)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (54)
¹ÙÀÌ¿ÀÀåºñ (357)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (131)
À¯ÀüÀÚ Ä¡·á/RNAi (101)
Àç»ýÀÇÇÐ (124)
Ç×ü/¸é¿ª (191)
½ÃÀ庸°í¼­

U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 05¿ù »óǰÄÚµå 66647
ÆäÀÌÁö Á¤º¸ 184 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, organ transplantation, cardiovascular disorders, infectious diseases, and other indications. Major market challenges, drivers, and restraints and identified and discussed.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary
    • Introduction

2 MARKET INTRODUCTION

  • Research Scope and Methodology
    • Scope & Segmentation
    • Research Methodology
  • Market Overview
    • Market Engineering Measurements
    • Technology Overview
    • Disease Overviews - Oncology
    • Disease Overviews - Autoimmune and Inflammatory Disorders
    • Disease Overviews - Organ Transplantation
    • Disease Overviews - Cardiovascular Disorders
    • Disease Overview - Infectious Diseases
    • Disease Overviews - Other Diseases
    • Industry Trends
    • Industry Challenges
    • Market Drivers
    • Market Restraints
  • Product Analysis
    • Oncology
    • Autoimmune and Inflammatory Disorders
    • Organ Transplantation
    • Cardiovascular Disorders
    • Infectious Diseases
    • Other Indications
  • Pipeline Analysis
    • Oncology
    • Autoimmune and Inflammatory Disorders
    • Organ Transplantation
    • Cardiovascular Disorders
    • Infectious Diseases
    • Other Indications
    • Additional Indications for Marketed Products

3 COMPETITIVE ANALYSIS

  • Competitive Analysis
    • Competitive Structure
  • Forecasts and Trends
    • Total Market
    • Oncology
    • Autoimmune and Inflammatory Disorders
    • Organ Transplantation
    • Cardiovascular Disorders
    • Infectious Diseases
    • Other Indications
  • Market Share Analysis
    • Company Market Share
    • Product Market Share

4 DECISION SUPPORT DATABASES

  • Oncology Databases
    • Incidence of Colon Rectum Cancer
    • Total Cancer Cases
    • Incidence of Bladder Cancer
    • Incidence of Breast Cancer
    • Incidence of Lung Cancer
    • Incidence of Stomach Cancer
  • Autoimmune and Inflammatory Disorders Databases
    • Prevalence of Asthma
    • Prevalence of Arthritis
    • Total Cases of Multiple Sclerosis
    • Prevalence of Psoriasis
  • Organ Transplant Databases
    • Total Number of Kidney Transplants
    • Total of Heart Transplants
    • Total Number of Liver Transplants
  • Cardiovascular Databases
    • Prevalence of Cardiovascular Diseases
    • Prevalence of Coronary Heart Disease
  • Other Indications Databases
    • Prevalence of Age-Related Macular Degeneration (AMD)
Back to Top